Celemics, Inc. (KOSDAQ:331920)

Market Cap	25.51B
Revenue (ttm)	6.23B
Net Income (ttm)	-4.92B
Shares Out	8.16M
EPS (ttm)	-603.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,960
Average Volume	14,629
Open	2,970.00
Previous Close	2,995.00
Day's Range	2,970.00 - 3,015.00
52-Week Range	2,620.00 - 4,870.00
Beta	0.81
RSI	58.67
Earnings Date	Aug 14, 2025

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920